These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35822242)

  • 41. Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer.
    Bai XM; Yang W; Zhang ZY; Jiang AN; Wu W; Lee JC; Chen MH; Yan K
    Int J Hyperthermia; 2019 Jan; 35(1):183-193. PubMed ID: 30200791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
    Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy.
    Fan XX; Lv SY; Zhang MW; Dai XY; Zhao JP; Mao DF; Zhang Y
    World J Surg Oncol; 2020 Apr; 18(1):76. PubMed ID: 32312256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
    Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
    Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival.
    Veltri A; Guarnieri T; Gazzera C; Busso M; Solitro F; Fora G; Racca P
    Radiol Med; 2012 Oct; 117(7):1139-51. PubMed ID: 22430677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases.
    Li X; Wang J; Li W; Huang Z; Fan W; Chen Y; Shen L; Pan T; Wu P; Zhao M
    Int J Hyperthermia; 2012; 28(8):721-8. PubMed ID: 23153217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases.
    White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Smyth EF; Hartley JE; Monson JR
    Dig Surg; 2004; 21(4):314-20. PubMed ID: 15365230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison study of computed tomography-guided radiofrequency and microwave ablation for pulmonary tumors: A retrospective, case-controlled observational study.
    Chi J; Ding M; Shi Y; Wang T; Cui D; Tang X; Li P; Zhai B
    Thorac Cancer; 2018 Oct; 9(10):1241-1248. PubMed ID: 30070054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma.
    Yan TD; King J; Sjarif A; Glenn D; Steinke K; Al-Kindy A; Morris DL
    Ann Surg Oncol; 2007 May; 14(5):1718-26. PubMed ID: 17285398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung disease.
    Tselikas L; Garzelli L; Mercier O; Auperin A; Lamrani L; Deschamps F; Yevich S; Roux C; Mussot S; Delpla A; Varin F; Hakime A; Teriitehau C; Le Péchoux C; Pradère P; Caramella C; Besse B; Fadel E; de Baere T
    Diagn Interv Imaging; 2021 Jan; 102(1):19-26. PubMed ID: 33020025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Outcomes and Predictors in Patients With Unresectable Colorectal Cancer Liver Metastases Following Salvage Percutaneous Radiofrequency Ablation: A Single Center Preliminary Experience.
    Wang Y; Zhang GY; Xu LC; He XH; Huang HZ; Li GD; Wang YH; Wang GZ; Li WT
    Technol Cancer Res Treat; 2020; 19():1533033820963662. PubMed ID: 33034276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases.
    Di Martino M; Rompianesi G; Mora-Guzmán I; Martín-Pérez E; Montalti R; Troisi RI
    Eur J Surg Oncol; 2020 May; 46(5):772-781. PubMed ID: 31862133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin.
    Hompes D; Prevoo W; Ruers T
    Cancer Imaging; 2011 Mar; 11(1):23-30. PubMed ID: 21435988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma.
    Lee SJ; Kim JH; Kim SY; Won HJ; Shin YM; Kim PN
    Korean J Radiol; 2020 Mar; 21(3):316-324. PubMed ID: 32090524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis.
    Abitabile P; Hartl U; Lange J; Maurer CA
    Eur J Surg Oncol; 2007 Feb; 33(1):67-71. PubMed ID: 17174059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience.
    Huang J; Xie X; Lin J; Wang W; Zhang X; Liu M; Li X; Huang G; Liu B; Xie X
    Cancer Imaging; 2019 Jun; 19(1):44. PubMed ID: 31242934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiofrequency Ablation for Colorectal Cancer Liver Metastases: Outcomes and Prognostic Factors Associated with Survival.
    Akhan O; Akçalar S; Ünal E; Metin Y; Çiftçi T; Akıncı D
    Turk J Gastroenterol; 2023 Jun; 34(6):645-651. PubMed ID: 37232461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Three-year Survival Rate after Radiofrequency Ablation for Surgically Resectable Colorectal Lung Metastases: A Prospective Multicenter Study.
    Hasegawa T; Takaki H; Kodama H; Yamanaka T; Nakatsuka A; Sato Y; Takao M; Katayama Y; Fukai I; Kato T; Tokui T; Tempaku H; Adachi K; Matsushima Y; Inaba Y; Yamakado K
    Radiology; 2020 Mar; 294(3):686-695. PubMed ID: 31934829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
    Laimer G; Jaschke N; Schullian P; Putzer D; Eberle G; Solbiati M; Solbiati L; Goldberg SN; Bale R
    Eur Radiol; 2021 Sep; 31(9):6489-6499. PubMed ID: 33447860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy.
    Knudsen AR; Kannerup AS; Mortensen FV; Nielsen DT
    Acta Radiol; 2009 Sep; 50(7):716-21. PubMed ID: 19488894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.